Following exocytosis, the rate of recovery of neurotransmitter release is determined by vesicle retrieval from the plasma membrane and by recruitment of vesicles from reserve pools within the synapse, which is dependent on mitochondrial ATP. The anti-apoptotic Bcl-2 family protein Bcl-x L also regulates neurotransmitter release and recovery in part by increasing ATP availability from mitochondria. We now find, that Bcl-x L directly regulates endocytic vesicle retrieval in hippocampal neurons through protein-protein interaction with components of the clathrin complex. Our evidence suggests that, during synaptic stimulation, Bcl-x L translocates to clathrin-coated pits in a calmodulin-dependent manner and forms a complex with the GTPase Drp1, Mff and clathrin. Depletion of Drp1 produces misformed endocytic vesicles. Mutagenesis studies suggest that formation of the Bcl-x L -Drp1 complex is necessary for the enhanced rate of vesicle endocytosis produced by Bcl-x L , thus providing a mechanism for presynaptic plasticity. AUTHOR CONTRIBUTIONS H.L. performed experiments, analyses and intellectual contributions; K.N.A. prepared novel reagents, performed experiments, analyses, intellectual contributions and prepared figures; E.L. assisted K.N.A. in preparing reagents and performing experiments; N.M. performed experiments and analyses; A.J. performed experiments and analyses; P.Z. performed experiments and analyses; P.L. prepared novel reagents for experiments; M.G. performed EM experiments; T.U. prepared novel reagents and performed experiments and analyses; J.G. performed experiments; C.R. supervised EM experiments; R.S.D. supervised work performed by P.L.; R.S.M. provided intellectual contribution and supervised experiments performed by T.U.; E.A.J. performed analyses, wrote the manuscript and provided intellectual contributions for, supervision of, and conception and planning of the project.
Bcl-2 family proteins participate in cell death [1] [2] [3] [4] [5] [6] [7] but one member of the family, Bcl-x L , is the predominant anti-apoptotic protein expressed in healthy adult brain 8 , suggesting that it performs other physiological functions. In hippocampal neurons, overexpression of Bcl-x L markedly changes synaptic morphology 9 . In the squid giant presynaptic terminal, recombinant Bcl-x L protein enhances the rate of recovery of neurotransmission following intense synaptic activity 10 and the Bcl-2/Bcl-x L inhibitor ABT-737 slows recovery 11 .
Bcl-x L also regulates neuronal metabolism by enhancing the efficiency of mitochondrial ATP production 12 . Mobilization of synaptic vesicles from the reserve pool depends on mitochondria 13 . Following physiological exoctyosis, however, recovery of neurotransmitter pools is also determined by endocytic retrieval of vesicles directly from the plasma membrane. The molecular machinery regulating retrieval includes the clathrin coat, which interacts with molecules that catalyse fission of synaptic vesicles from the plasma membrane 14, 15 and calciumdependent proteins and phosphatases that catalyse endocytosis 16, 17 . Both reserve pool mobilization and direct plasma membrane retrieval contribute to recovery in hippocampus 18 .
We have now found using imaging techniques in hippocampal neurons that Bcl-x L regulates recovery to a fast-releasing vesicle pool. Surprisingly, enhanced vesicle recovery produced by Bcl-x L occurs even when effects of mitochondrial ATP are eliminated. Bcl-x L -regulated recovery depends on stimulation, calmodulin and Bcl-x L translocation to clathrin-coated pits. At synaptic vesicles, Bcl-x L forms protein-protein interactions with the dynamin-like GTPase Drp1. Depletion of Drp1 or disruption of its interaction with Bcl-x L slows endocytosis and produces aberrantly shaped vesicle membranes. We suggest that a Bcl-x L -Drp1-clathrin complex directly enhances vesicle retrieval from the plasma membrane and contributes to enlargement of a fast-releasing pool during presynaptic plasticity.
RESULTS

Bcl-x L overexpression enhances the release rate of styryl dyes in hippocampal neurons
To study the role of Bcl-x L in vesicle exo-and endocytosis, we overexpressed GFP-Bcl-x L or GFP control lentivirus constructs in cultured hippocampal neurons (days in vitro (DIV) 14; ref. 9) and measured the kinetics of release of the styryl dye FM5-95 at individual synapses after loading with 47 mM KCl and 2 mM CaCl 2 for 90 s, a protocol reported to label recycling vesicles [19] [20] [21] (Fig. 1a, Exp 1 ). Peak fluorescence of labelled presynaptic clusters and total change in fluorescence ( F) were significantly higher in Bcl-x L -overexpressing cells when compared with controls ( Fig. 1d and Supplementary Fig. S1a previous findings that Bcl-x L increases presynaptic vesicle cluster size by light and electron microscopy 9 . Greater than 90% of dye was released within the first 90 s of stimulation in 90 mM KCl ( Supplementary  Fig. S1b ); therefore, only the first 90 s are shown in subsequent studies. In controls, release kinetics at room temperature were well fitted with a single exponential ( Fig. 1b ,e,f); in all control experiments, fewer than 20% of puncta exhibited bi-exponential kinetics of fluorescence decline. Relative weights of fits to rapid and slow components of release demonstrated that release in control cells had little or no rapid component (Fig. 1g) . In contrast to controls, the kinetics of dye release in more than 90% of Bcl-x L -overexpressing neurons required a fit with two exponentials ( Fig. 1b ,e,f); the rapid component of release represented as much as one-third or more of the total release ( Fig. 1g ). These data show that both controls and Bcl-x L -expressing cells have a slowly releasing pool, but that Bcl-x L -overexpressing cells have an additional pool that releases more rapidly. Vesicle pool loading is regulated by calcium influx 20 . To determine whether increased pool loading was related to calcium influx, calcium responses in GFP-Bcl-x L and control GFP-expressing cells were monitored with the calcium indicator Fluo-4 during stimulation with 100 action potentials at 10 Hz. No difference in calcium levels at boutons between Bcl-x L -overexpressing cells and controls was detected ( Fig. 1c ), suggesting that differences in calcium influx at release sites do not contribute to differences in vesicle release.
In hippocampal neurons, filling of the fast-releasing pool takes longer than it does, for example, in the Calyx of Held 17, 22 ; therefore refilling of the fast-releasing pool might take longer in controls when compared with Bcl-x L -expressing cells. To investigate this, we allowed for continued dye loading after stimulation during a 5 min re-filling period 20 (Fig. 1a , Exp 2). Using this protocol Bcl-x L -overexpressing cells again demonstrated larger peak fluorescence than control neurons ( Fig. 1h and Supplementary Fig. S1a ), but kinetics of dye release from both Bcl-x L and control neurons now required a fit with two exponentials ( Fig. 1i-k) . Therefore, like Bcl-x L cells, control cells have a rapidly releasing pool, but this pool takes longer to fill than in Bcl-x L cells.
The late-filling fast-releasing pool may continue to fill long after stimulation has ceased. If the fast-releasing pool fills faster in Bcl-x Loverexpressing cells, then there should exist a time after stimulation that the fast-releasing pool would be filled in the Bcl-x L -expressing cells but not in controls. To investigate whether controls fill the fast-releasing pool long after stimulation, dye was presented for 90 s only at 3 min after the end of stimulation ( Fig. 1a , Exp 3). In both controls and Bcl-x L -overexpressing cells, there was a lower level of peak fluorescence than in Exp 1 and 2 ( Fig. 1l and Supplementary Fig. S1a ), suggesting only partial filling of recovering pools; the filled pool sizes, however, of the two cell types were now not different from each other; therefore, a large portion in Bcl-x L -overexpressing cells filled early. In addition, in Bcl-x L cells, there was complete elimination of bi-exponential kinetics, suggesting that Exp 3 eliminated filling of the fast-releasing pool ( Fig. 1m-o) . In controls however, release kinetics of some cells now required bi-exponential fits (Fig. 1n,o ), suggesting very late re-filling of the fast-releasing pool.
Endogenous Bcl-x L participates in normal vesicle pool dynamics
To determine whether endogenous Bcl-x L regulates normal exo/endocytosis we reduced levels of Bcl-x L with Bcl-x L short hairpin RNA (shRNA) or scrambled shRNA lentivirus and studied release properties of the recycling pool (Exp 1; Fig. 2a and Supplementary  Fig. S1a ). Cells expressing Bcl-x L shRNA had decreased peak fluorescence when compared with controls ( Fig. 2b and Supplementary  Fig. S1a ), confirming an effect on overall pool size 9 . Kinetics of the slowly releasing pool were decreased in Bcl-x L -depleted cells ( Fig. 2c-e ), suggesting that Bcl-x L regulates the rate of exo/endocytosis of both the rapidly and slowly releasing pools.
Bcl-x L acts downstream of calmodulin to enhance endocytosis
Re-filling of at least two vesicle pools in the Calyx of Held is dependent on calcium/calmodulin 23, 24 ; therefore, inhibition of calmodulin could affect pool dynamics in hippocampal cells. Control neurons treated with the calmodulin inhibitor calmidazolium (CaMi, 20 µM for 30 min) during exo/endocytosis to the recycling pool manifested decreased peak fluorescence ( Fig. 2f and Supplementary Fig. S1a ) and a decreased time constant (τ ) of release ( Fig. 2g-i ), suggesting that CaMi prevented re-filling of a slowly releasing pool. If CaMi-sensitive pools were sensitive to Bcl-x L , then Bcl-x L overexpression might rescue release kinetics in CaMi-exposed neurons. Consistent with this, CaMi treatment failed to decrease peak fluorescence in Bcl-x L -overexpressing cells ( Fig. 2j ) and, although CaMi slowed bi-exponential kinetics ( Fig. 2k,l) , Bcl-x L rescued the fast-releasing pool in CaMi-treated cells ( Fig. 2m ). Therefore, Bcl-x L could act downstream of calmodulin in re-filling of vesicle pools.
Bcl-x L increases rate of endocytosis in synaptopHluorin-expressing neurons
Experiments on exo-and endocytosis using styryl dyes provide an indirect measure of the kinetics of endocytosis 25 . A direct measure is obtained using synaptopHluorin, a green fluorescent synaptic vesicle protein that increases its fluorescence on exocytosis, when the lumen of synaptic vesicles is exposed to the relatively high pH of the external medium [26] [27] [28] [29] . On endocytosis, fluorescence intensity declines, and the kinetics of decline reflect the rate of vesicle retrieval plus the rate of re-acidification of the vesicle lumen 29 . Using synaptopHluorin, Bcl-x L -overexpressing cells had higher peak fluorescence when compared with controls during stimulation, as expected by the increased pool size ( Fig. 3a ). In addition, the time constant of the decrease in fluorescence following the end of stimulation was faster than in controls ( Fig. 3a inset) . Bcl-x L -overexpressing cells had an increase in peak fluorescence when compared with control cells after addition of the vesicle re-acidification inhibitor bafilomycin (control data shown in Fig. 3b,d ; Bcl-x L -overexpressing cell data shown in Fig. 3c,d ), suggesting that Bcl-x L -overexpressing neurons perform more endocytosis during exocytosis when compared with controls. In contrast, neurons expressing DsRed-Bcl-x L shRNA had slower fluorescence decline ( Fig. 3e and inset) and a decrease in peak fluorescence in bafilomycin (controls shown in Fig. 3f inhibitor ABT-737 (refs 11,30; Fig. 3j ) also decreased the rate of decline in synaptopHluorin fluorescence after stimulation when compared with that measured before ABT-737 exposure ( Fig. 3j inset) .
Reports have emphasized a role for Bcl-x L in enhancing ATP availability for cell survival 12, 31 . If the sole effect of Bcl-x L were to enhance ATP production by mitochondria the effects of Bcl-x L on vesicle dynamics would be eliminated under conditions of fixed ATP such as in autaptically synapsing cells patch-clamped with ATP (1 mM) in the recording pipette ( Fig. 3k ; see Methods). Under these conditions, synaptic depression was less in Bcl-x L -overexpressing cells than controls ( Fig. 3l,m ), suggesting that Bcl-x L relieved synaptic depression, in part in an ATP-independent manner. To eliminate mitochondrial ATP production altogether, we exposed cells to the F 1 F O ATP synthase enzymatic inhibitor oligomycin. In the absence of oligomycin, as previously reported 12 , overexpression of Bcl-x L increased ATP levels over control neurons (Fig. 3n ); 5 min of exposure to oligomycin completely eliminated this difference ( Fig. 3n ). Oligomycin also prolonged the time course of endocytosis more in controls than cells * (l) Synaptic depression of GFP-Bcl-x L or control GFP (10 Hz stimulation, first and last 10 of 100 synaptic responses). (m) Summary data of percentage change in average amplitude of last 10 compared with first 10 synaptic responses (n = 8 control GFP and 9 GFP-Bcl-x L cells, 2 independent cultures; * P = 0.017). (n) ATP levels (luciferin/luciferase) of lysed neurons expressing the indicated constructs; oligomycin = 5 µg ml −1 for 5 min; n = 12 wells each group, * * * P < 0.0001). (o) Normalized fluorescence in 5 µg ml −1 oligomycin (stimulation 5 min after oligomycin application, n = 10 puncta each from DsRed-Bcl-x L -or mito-RFP-(ctl) expressing cells). (p) Time constants (τ ) of change in fluorescence after stimulation for data in o (n = 10 for oligomycin-treated samples, n = 37 for non-oligomycin treated samples). * * * P < 0.0001 except for right-most comparison where P = 0.0005. (q) Normalized fluorescence before and after 5 µM bafilomycin in oligomycin-treated cells (n = 10 puncta, 3 independent coverslips; mito-RFP controls). (r) Normalized fluorescence before and after 5 µM bafilomycin in oligomycin-treated cells (n = 10 puncta, 3 independent coverslips, DsRed-Bcl-x L ). (s) Ratio of difference in peak fluorescence before and after bafilomycin over peak in bafilomycin of traces shown in q,r ( * * * P < 0.0001). Statistics are represented as mean ± s.e.m.
overexpressing Bcl-x L (Fig. 3o,p) . Nevertheless, the difference in ratio of peak fluorescence before and after bafilomycin exposure comparing Bcl-x L -expressing cells with controls ( Fig. 3q -s) was preserved in the presence of oligomycin (compare Fig. 3s to Fig. 3d ). These data suggest that a portion of early endocytosis in Bcl-x L -expressing neurons is unaffected by loss of mitochondrial ATP. 
Neuronal stimulation promotes calmodulin-dependent Bcl-x L translocation to synaptic vesicle membranes
During strong synaptic stimulation or injurious stimuli such as ischaemia in neurons, large amounts of calcium enter the cell and are buffered by calcium buffering proteins, mitochondria and the endoplasmic reticulum. In cells that have received such stimuli, Bcl-x L translocates to intracellular membranes perhaps to enhance synaptic responses and protect against cell injury [32] [33] [34] [35] . To measure acute translocation of Bcl-x L to intracellular membranes after stimulation, cells were immediately lysed and subjected to subcellular fractionation for Bcl-x L immunoanalysis. The level of contamination of subcellular fractions with proteins specific to other fractions was low either before or after stimulation ( Supplementary Fig. S2d ) and the fraction containing synaptic vesicle protein (synaptotagmin-1) was relatively devoid of post-synaptic protein (PSD-95), presynaptic compartment or presynaptic membrane proteins ( Supplementary  Fig. S2e ). Levels of endogenous Bcl-x L after stimulation decreased in the cytosol and increased in mitochondria and in the synaptic vesicle membrane compartment ( Fig. 4a,b ). Bcl-x L translocation was largely prevented by pre-treatment with CaMi ( Fig. 4a,b ), suggesting that calmodulin is upstream of translocation. To rule out nonspecific effects of calmodulin inhibition, neurons were depleted of endogenous calmodulin by shRNA (calmodulin protein blot Supplementary  Fig. S2c ). Translocation of Bcl-x L was largely prevented in calmodulindepleted cultures ( Fig. 4c,d ), suggesting that calmodulin is necessary for Bcl-x L translocation to both mitochondria and synaptic vesicle membranes during neuronal activity. Endogenous calmodulin also regulated early endocytosis, because neurons expressing calmodulin shRNA had a lower ratio of endocytosis to exocytosis measured with and without bafilomycin ( Fig. 4e -g) and a slower rate of synaptopHluorin fluorescence decline ( Fig. 4h and inset) .
Bcl-x L and Drp1 co-localize with clathrin on synaptic vesicles and Drp1 regulates endocytic vesicle morphology
Previous work suggested that Bcl-x L co-localizes with and activates, through protein-protein interaction, the GTPase activity of Drp1 (refs 9,36) . Drp1 is a large dynamin-like GTPase usually associated with mitochondrial fission events in both physiological and pathological settings 9, [36] [37] [38] [39] [40] . We therefore determined whether Drp1, in its role as a dynamin-like GTPase, might regulate endocytosis. Indeed, immuno-electron micrographs demonstrated that Drp1, although clearly localized in part to mitochondria ( Supplementary Fig. S3a ) was also co-localized with clathrin at clathrin-coated pits in neurons fixed just after stimulation ( Fig. 5a ) and translocated to synaptic vesicles in a stimulation-calmodulin dependent manner ( Supplementary  Fig. S3b ). Furthermore, clathrin, Bcl-x L and the Drp1 mitochondrialtargeting protein Mff, but not dynamin or non-vesicular proteins (PSD-95 or Cacna1a), were present in immunoblots of brain tissue immunoprecipitated with anti-Drp1 antibody (Fig. 5b) . The Bcl-x L -Drp1-Mff-clathrin complex was also present in the purified synaptic vesicle fraction ( Fig. 5c,d) . The anti-Drp1 antibody was specific to Drp1 in that it did not recognize dynamin in brain lysates; the anti-Dynamin I and II antibody was also specific in brain lysates ( Supplementary Fig. S3c ).
Bcl-x L co-localizes with and activates the GTPase activity of Drp1 to alter membrane properties 9, 41 . To investigate whether Drp1 influences normal exo/endocytosis, synaptopHluorin-expressing neurons were depleted of Drp1 by lentivirus encoding shRNA ( Supplementary Fig. S2f ); depletion of Drp1 was confirmed by immunoblots ( Supplementary Figs S2g,h ) and in randomly generated immuno-electron micrographs of equal numbers of synaptic profiles ( Supplementary Fig. S2i ). We found previously that depletion of Drp1 or expression of a dominant-negative defective Drp1 does not prevent mitochondrial entry into axons and dendrites, but increases the length of mitochondria in neuronal processes 9, 36, 42 . In the present study, Drp1 depletion increased individual mitochondrial area measured in electron micrographs (0.14 ± 0.02 µ 2 , n = 18 mitochondria in controls compared with 0.30 ± 0.03 µ 2 , n = 20 mitochondria in Drp1 shRNA, P = 0.0011), consistent with hyperfused mitochondria. Both peak fluorescence and rate of synaptopHluorin re-uptake in Drp1 depleted cells were decreased when compared with scrambled shRNA controls ( Fig. 5e ) but Drp1 depletion was rescued by overexpression of an shRNA-resistant Drp1 construct, suggesting that Drp1 is specifically required for normal exo/endocytosis (Fig. 5f ). Peak fluorescence ratio of bafilomycin-treated cells expressing Drp1 shRNA was decreased when compared with controls (control data shown in Fig. 5g ,i; Drp1 shRNA data shown in Fig. 5h,i) , indicating that Drp1, like Bcl-x L , is necessary for early vesicle re-uptake during exocytosis.
Drp1 is recruited to mitochondria through the mitochondrialtargeting factor Mff (ref. 43) . Mff co-immunoprecipitated with Drp1 in brain lysates, but also in purified synaptic vesicle lysates ( Fig. 5b-d) and also co-immunoprecipitated with the specific vesicle membrane protein synaptotagmin (Fig. 5j ). Depletion of Mff by shRNA produced a decline in the rate of endocytosis and a decrease in early endocytosis (Fig. 5k-m) . Taken together, the findings suggest that Mff may serve as the targeting protein for Drp1 to synaptic vesicle membranes and that Mff contributes to vesicle retrieval from the plasma membrane after stimulation.
Bcl-x L and Drp1-Mff previously were known to function at mitochondrial membranes, not synaptic vesicle membranes. Therefore, to confirm localization at synaptic vesicle membranes, immunogold electron microscopy was performed. Clathrin was co-localized with Bcl-x L at clathrin-coated pits in control synapses (Fig. 6a ). Bcl-x L was present in brain tissue immunoprecipitated with anti-clathrin antibody (Fig. 6b ), although synaptic proteins that are known not to bind clathrin (dynamin, Cacna1a and PSD-95) were absent, suggesting specific association of Bcl-x L with clathrin. Formation of the Bcl-x L -clathrin complex depended on neuronal stimulation: gold particles labelled with antibodies against clathrin and Bcl-x L were increasingly co-localized after stimulation (n = 27) when compared with non-stimulated synapses (n = 25; Fig. 6c ).
Bcl-x L and Drp1 were found to be localized to mitochondria, but also at synaptic vesicle membranes with the presynaptic vesicle marker synaptophysin (Fig. 6d,f) . Labelling with synaptophysin was specific because it was restricted to synaptic vesicle membranes. Labelling of Bcl-x L and Drp1 was specific, because it was restricted to synaptic vesicle membranes and to mitochondria but little labelling was seen at other subcellular locations including post-synaptic sites (Fig. 6d,f) . Bcl-x L and Drp1 co-localized with synaptic vesicle components in a stimulation-dependent manner; both Bcl-x L and Drp1 were increased in synaptic profiles after stimulation and co-localization with synaptophysin was increased ( Fig. 6e) .
A morphologically apparent defect in endocytosis occurred in Drp1depleted resting cultured neurons ( Fig. 7a-c) . Images of scrambled-shRNA-expressing synapses only occasionally exhibited enlarged endosomal or vesicular structures (Fig. 7a) whereas images of Drp1-shRNA-expressing synapses showed multiple large vesicular structures (Fig. 7b ). In addition, measurable synaptic vesicle area in electron micrographs of Drp1-depleted synapses was more variable and contained larger vesicles than controls (Fig. 7c ). It is likely that enlarged structures represent either vesicles delayed in the process of endocytosis, enlarged as a result of abnormally flat membrane curvature or abnormally fused with partner vesicles.
Electron micrographs of stimulated horseradish peroxidase (HRP)labelled synapses demonstrated a similar bizarre endosomal phenotype as seen in non-stimulated neurons, and this phenotype was rarely present in controls (Fig. 7d) . As was the case for non-stimulated synapses, the average area of HRP-labelled vesicles was significantly larger in Drp1-depleted cells when compared with controls (Fig. 7e) . The large endosomal structures in stimulated Drp1-depleted neurons co-localized with the specific synaptic vesicle protein VAMP on immuno-electron micrographs (Fig. 7f,i ), suggesting that they had ) from panels in f,g (n = 8 micrographs of control scrambled shRNA unstimulated synapses, n = 5 micrographs of control scrambled shRNA stimulated synapses, n = 9 micrographs of Drp1 shRNA unstimulated synapses, n = 12 micrographs of Drp1 shRNA stimulated synapses, n = 19 micrographs of Drp1 shRNA synapses immunogold labelled with anti-VAMP antibodies). (j) Quantification of number of vesicles in synapses such as shown in g (n = 9 micrographs (synapses) each for unstimulated and stimulated scrambled shRNA, 9 micrographs for unstimulated Drp1 shRNA, 11 micrographs for stimulated Drp1 shRNA; * P = 0.0306, * * P = 0.002, * * * P < 0.0001). (k) Quantification of synapse area (µm 2 ) of all synapses measured in j ( * P = 0.043; * * P = 0.007, * * * P < 0.0001). Statistics are represented as mean ± s.e.m.
in Fig. 7i ), suggesting that abnormal structures may be delayed in devolving into normal vesicles.
In normal neurons undergoing stimulation, the plasma membrane perimeter (synapse profile area) may increase as exocytotic membrane is added to it; concomitantly the number of intra-synaptic vesicles is decreased after fusion 44 . We found in control neurons that the area of synaptic profiles was not changed after stimulation, but that the number of synaptic vesicles was decreased (Fig. 7j,k) . In contrast, in Drp1-depleted cells, the number of synaptic vesicles was unchanged after stimulation but synaptic profile area was decreased, perhaps consistent with re-uptake of enlarged membranes and lack of re-formation of vesicles (Fig. 7j,k) . Interestingly, synaptic profile area and number of vesicles in unstimulated Drp1-depleted synapses were significantly decreased when compared with unstimulated controls, consistent with the notion that Drp1-depleted synapses are unable to maintain normal vesicle pool sizes.
Bcl-x L -Drp1 interaction is required for regulation of endocytosis
To confirm the role in endocytosis of the Bcl-x L -Drp1 complex, mutations in Bcl-x L were designed de novo. We mutated conserved amino acids between human Bcl-x L and Bcl-2-like protein CED-9 of Caenorhabditis elegans, because both proteins interact with Clathrin L K   25  50  75  91   116  141  166  182   207  232  257  273   298 323 334
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Bcl-x L Ced-9 Drp1 (refs 9,45) . Mutation of three consecutive conserved aminoacid residues in the BH1 domain and three conserved residues in the BH2 domain generated constructs M1 and M2 (Fig. 8a) . Immunoprecipitation by anti-FLAG antibody of wild-type and M1 FLAG-tagged Bcl-x L proteins pulled down overexpressed Drp1 in HEK293T cells, whereas FLAG-tagged M2 Bcl-x L protein failed to interact with overexpressed Drp1 (Fig. 8b) . Overexpression of wild-type Bcl-x L and M1 equally enhanced synaptopHluorin responses in hippocampal neurons, but overexpression of M2 failed to enhance responses over the control level (Fig. 8c,d) . The synaptopHluorin experiments and analyses were performed by an operator blinded to the results of the co-immunoprecipitation studies. The Bcl-x L -Drp1 complex therefore enhances endocytosis through a mechanism involving direct interaction between the two proteins ( Fig. 8e) .
DISCUSSION
We suggest that Bcl-x L , previously known to protect against cell death, also regulates vesicle endocytosis in hippocampal neurons. We show that Bcl-x L interacts in a complex with clathrin and Drp1 to alter the kinetics of vesicle pool recovery.
We have previously shown in squid that Bcl-x L protein enhances recovery to a rapidly releasing neurotransmitter pool following synaptic depression 10 and that endogenous Bcl-x L regulates this recovery 11 . Although at least two pools regulate vesicle recovery at the Calyx of Held and in squid, hippocampal presynaptic terminals do not exhibit the same fast time kinetics as these synapses 10, 17 . Although previous work in other synapses suggested that transmitter recovery was regulated by mitochondria 10, 13 , we find a pool in hippocampus that is resistant to mitochondrial metabolism. Nevertheless, it is likely that other synaptic processes in hippocampus are dependent on mitochondrial function 9, 46 .
Release kinetics in the hippocampus are determined by calciumdependent synaptic vesicle priming, fusion and recycling. In support of a role for calcium-dependent processes, we find that inhibition of calmodulin by pharmacological or genetic means prevents Bcl-x L and Drp1 translocation to synaptic vesicles during stimulation and prevents normal vesicle pool recovery. In this form of clathrindependent endocytosis, we find that Bcl-x L and Drp1 act downstream of calcium influx/calmodulin. Our studies are also consistent with recent results defining a role for calmodulin in vesicle release probability 47 . Indeed, our electron micrographs of Drp1-depleted cells demonstrate a lack of change in vesicle number after stimulation, suggesting defective exocytosis.
Previous studies support a role for Bcl-2 family proteins including Bcl-x L in altering lipid membrane morphology in cell-free systems [48] [49] [50] [51] .
Bcl-x L may change membrane morphology through its actions on Drp1. GTPases participate in membrane fission events of several subcellular organelles. Drp1 acts downstream of Bcl-x L (refs 9,36) and upstream of endophilin B1 in regulating mitochondrial membrane remodelling 52 . Endophilin family members also play a role in synaptic endocytosis [53] [54] [55] [56] . In addition to their interactions with endophilins, the GTPases at vesicles also interact with AP2, epsin, amphiphysin and AP180 (refs 15, 57) . We find that interaction of Bcl-x L with Drp1 is necessary for normal vesicle retrieval; a mutation in the Bcl-x L BH2 domain decreases interaction with Drp1 and inhibits Bcl-x L -induced increase in endocytosis rate. We find that the mitochondrial-docking protein Mff (ref. 43 ) also recruits Drp1 to synaptic vesicles. However, the mechanism by which Mff recruits Drp1 to synaptic vesicles versus mitochondria is not known.
Drp1 has been implicated previously, albeit indirectly, in the regulation of synaptic vesicle endocytosis. In Drosophila synapses, Drp1 knockout produces loss of mitochondrial targeting to synapses and a metabolically dependent decline in sustained synaptic responses 13 . Previous work also supports a role for Drp1 in hippocampal synapse formation and enlargement. Expression of a dominant-negative form of Drp1 decreases mitochondrial targeting to synapses and decreases synapse formation even though it lengthens mitochondria in neuronal processes 9 . Nevertheless, a direct role for Drp1 at synaptic vesicle membranes has not been anticipated previously. Our present study shows that Drp1 depletion enlarges endocytic figures, creating abnormally flat membrane curvature, associated with delayed vesicle recovery to release ready pools. On the basis of our findings, the order of events in healthy synapses undergoing exo/endocytosis would be calcium entry into the terminal, activation of calmodulin, translocation of Bcl-x L -Drp1 to the synaptic vesicle membrane, binding of Bcl-x L -Drp1 to a complex including Mff and clathrin, enhancement of the rate of retrieved membrane to re-form into exocytosis-ready vesicles (Fig. 8e ). It is tempting to speculate on the basis of these data that a complex of proteins involving Bcl-x L , Drp1 and clathrin, in cooperation with other known vesicle-membrane-regulating proteins, is necessary for efficient endocytosis and presynaptic plasticity.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb2791
Primary cultures of rat hippocampal neurons and transfections. Primary
rat hippocampal neurons were prepared as described previously 58, 59 . Briefly, hippocampi were isolated from Sprague-Dawley rat embryos (embryonic day [18] [19] , and then incubated for 12 min with 0.03% trypsin. The hippocampal cells were dissociated by trituration through a polished Pasteur pipette. Neurons were plated on 0.1% (w/v) poly-L-lysine-(Peptides International) coated coverslips (Warner Instruments) at a density of 3-6 × 10 3 cm −1 . Cells were cultured in Neurobasal medium, supplemented with B-27 (Invitrogen), 0.5 mM glutamine, 25 µM glutamate and 5% fetal calf serum. Three to four hours after plating, the medium was replaced with serum-free Neurobasal supplemented with B-27 and 0.5 mM glutamine. Cultures typically contained few glial cells, started to form synapses after 6 days in vitro, and were used 9-20 days after plating. Neurons were transfected with 2.5 M calcium phosphate at day 5 after plating with an efficiency of ∼1-5%. Neurons were transduced with the lentiviral construct for Bcl-x L at DIV 4-7 and studied at DIV 12-18 with an efficiency of near 100%.
Viral constructs.
Lentiviruses expressing Bcl-x L with an amino-terminal GFP tag were used to transduce cultured hippocampal neurons. Full-length GFP-Bcl-x L was subcloned into a lentivirus vector c-FUW (ref. 60 ). Viral constructs were packaged in HEK293T cells by co-transfection with packaging plasmid delta 8.9 and envelope plasmid VSVG.48. Sixty hours after transfection, virus-containing supernatant was collected, stored at −80 • C, and used for transduction of cultured hippocampal neurons on DIV 5.
Autaptic primary hippocampal neuron culture. Briefly, the centre of each coverslip was treated with a 0.15% type IIA agarose solution and coverslips were dried for 1 h (ref. 61 ). Micro-islands were prepared 2 days before plating hippocampal neurons by spraying coverslips with 1:4 vol./vol. mixture of collagen and poly-d-lysine using a Glass micro-atomizer (Thomas Scientific). After drying, the coverslips were ultraviolet sterilized for 5 min then pre-incubated for 1 h with Neurobasal (+B27) medium+10%FBS before plating with dissociated hippocampal cells at a density of 0.2-0.6 × 10 4 cells ml −1 . Island cultures were maintained for upwards of 6 weeks, typically cells were recorded at DIV 30.
Lentiviral shRNA knockdown of Bcl-x L , Mff, calmodulin and Drp-1 and the shRNA-resistant constructs. The lentiviral plasmids expressing shRNAs were from Open Biosystems. Lentiviral plasmids for Drp1 shRNA were designed as in ref. 44 . The hairpin sequence against rat Bcl-x L was: 5 -CGGGCTCACTCTTCAGTCGGAATAGTGAAGCCACAGATGTATTCCGACT-GAAGAGTGAGCCCA-3 . For control, the scrambled, non-silencing shRNA sequence (Open Biosystems catalogue number RHS4346) was used. The lentivirus was produced according to published methods 58 . The pGIPZ vectors, containing either shRNA sequence against Bcl-x L or the scrambled sequence, were co-transfected with the packaging 8.9 and the vesicular stomatitis virus G protein vectors into HEK293T cells. Forty-eight hours after transfection, the supernatant was centrifuged at 50, 000g. The viral pellet was resuspended in PBS and added to the hippocampal neuronal cultures at DIV 5-7 and cells were studied at DIV 12-14. For the dsRed constructs, the shRNA sequences targeting rat Bcl-x L , calmodulin1+2 and Drp1 were cloned through a shuttle vector pCMV-U6 into a modified version of the lentiviral expression vector FlkURW (1) The Bcl-x L and Drp1 shRNA-resistant constructs were made using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies) according to the manufacturer's protocol.
Five and six silent mutations were placed, respectively, in the coding sequences of Bcl-x L and Drp1, cloned in FLAG and HA tag vectors. The sense sequences for the mutagenesis primers were: 5 -cccagaaaggatacagctggagCcaAttCagCgaCgtggaagagaacaggactgagg-3 for Bcl-x L and 5 -caacacggtgggcgccgacGtcGtcTagTtgTctTaaatcgtcgtagtgggaac-3 for Drp1.
Design of Bcl-x L mutants and
Bcl-x L -Drp1 interaction by co-immuno precipitation. To identify the specific Drp1-interacting domains on Bcl-x L , BLAST analysis was performed to identify the conserved amino acids between human Bcl-x L and CED-9 protein sequences. Two mutant constructs were produced, each carrying three substitutions for completely conserved amino acids on the BH1 or BH2 domains of Bcl-x L using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies) and the following primers: M1 5 -gtcgcattgtggcctttttctactgctgcggggcactg -3 ; 5 -cagtgccccgcagcagtagaaaaaggccacaatgcgac -3 M2 5 -ccaggagaacggcggctcggttacttgtgtggaactctatgg -3 ; 5 -ccatagagttccacacaagtaaccgagccgccgttctcctgg -3 . The resulting mutations were: (M1: S145Y, F146C, G147C) (M2: W188S, D189V, F191C) (Fig. 8a) . The constructs were expressed in HEK293T cells and immunoprecipitated, using the EZview Red ANTI-FLAG M2 Affinity Gel (Sigma), according to the manufacturer's protocol. The immunoprecipitation samples were examined by western blot analysis using a rabbit anti-Bcl-x L (Cell Signaling Technology) and a rabbit anti-Drp1 antibody (Santa Cruz Biotechnology; for details see the immunoblot section of the Methods).
Fluorescent measurement of pre-synaptic activity, using synaptopHluorin.
Neurons were co-transfected with RFP-Bcl-x L or mito-RFP and synaptopHluorin constructs using 2.5 M calcium phosphate on DIV 5. Transfection efficiency was about 1-5%. The synaptopHluorin-expressing neurons were assayed on DIV 14-18. The coverslips were mounted in the field stimulation chamber (platinum bath electrodes) on the stage of a microscope. The 50 µl chamber was perfused at a rate of 2 ml min −1 at room temperature with saline solution containing (in mM): 119 NaCl, 2.5 KCl, 2 CaCl 2 , 2 MgCl 2 , 25 HEPES and 30 glucose (buffered to pH 7.4, 300 mOsm). CNQX (10 µM) and AP5 (50 µM; Sigma) were added to the solution to prevent recurrent activity. Neurons were stimulated at 10 Hz (50 mA, 1 ms pulses) for 20 s. After 5 min at rest neurons were stimulated again at 10 Hz for 20 s in the presence of 5 µM bafilomycin A1 (Calbiochem/EMD Biosciences). Fluorescence values for baseline were obtained by averaging 3 images at rest before the stimulus. Time constant (τ ) of fluorescence responses of synaptopHluorin were measured from time-lapse images taken every 3 s. Quantitative measurements of fluorescence intensity at individual boutons were obtained by averaging 4 × 4 area pixels (0.4 × 0.4 µm 2 ) corresponding to the centre of individual puncta, selected by hand, background subtracted, and processed using Axiovision Measurement Suite.
Fluorescent measurement of pre-synaptic activity, using FM5-95 dye.
FM5-95 dye (Molecular Probes) was used at a final concentration of 30 µM. CNQX (10 µM) and AP5 (50 µM; Sigma) were added into Tyrode's solution to prevent recurrent activity. Experiments were done in pairs of control and Bcl-x Loverexpressing neurons. All experiments were performed at room temperature.
For the recycling pool loading protocol, FM5-95 dye was added to 47 mM high-K Tyrode's solution (47 mM KCl, 107 mM NaCl, 2 mM MgCl 2 , 10 mM glucose, 10 mM HEPES and 2 mM CaCl 2 (pH 7.4, 300 mOsm)) and put on cultured rat hippocampal cells. Neurons were given 90 s to load the dye, after which it was washed out with perfusion (2.5 ml min −1 ) of a modified Tyrode's wash solution (no-Ca 2+ ) containing 150 mM NaCl, 4 mM KCl, 2 mM MgCl 2 , 10 mM glucose and 10 mM HEPES (pH 7.4, 300 mOsm). Wash was performed for 2 min. Ninety images were taken with a 1 s interval between each while cells were being stimulated with 90 mM KCl in Tyrode's solution (90 mM KCl, 64 mM NaCl, 2 mM MgCl 2 , 10 mM glucose, 10 mM HEPES and 2 mM CaCl 2 (pH 7.4, 300 mOsm)).
For the extended load time protocol, FM5-95 dye was added to 47 mM K + Tyrode's solution for 90 s. The high-KCl-containing solution was washed out (2.5 ml min −1 ) with modified Tyrode's wash solution containing FM5-95 for 5 min. Then, the dye was washed out by modified Tyrode's wash solution (2 min, 2.5 ml min −1 ) lacking FM5-95 for 2 min. Cells were stimulated with 90 mM high-K + Tyrode's solution for 90 s, while images were taken with a 1 s interval between each image.
For the delayed labelling protocol, cells were stimulated with 47 mM KCl for 90 s without FM5-95 dye, followed by a constant wash (2 min, 2.5 ml min −1 ) for 2-4 min. FM5-95 dye was then added to the wash for 90 s followed by a wash (2 min, 2.5 ml min −1 ). Cells were then stimulated with 90 mM high-K Tyrode's solution while 90 images were taken with a 1 s interval between each image.
Image analysis. Images were analysed using Axiovision LE software and Microsoft
Excel. The fluorescence signal of each SV punctum (4 × 4 area pixels) was outlined and measured for all 90 images. A background measurement for each image was subtracted from the measurement of each punctum.
Calcium measurement. Neurons were loaded with 5 µM Fluo-4AM calcium indicator (Molecular Probes: F14201) and incubated at 37 • C for 30 min in the dark. Fluorescent axonal varicosities correspond to synaptic boutons along hippocampal cell axons detected in phase images of the cultured neurons according to the methods of ref. 62 .
Fluorescence values for baseline were obtained by averaging 3 images at rest before the stimulus. Cells were stimulated with 100 stimuli (50 mA, 1 ms) at 10 Hz. The time constant of fluorescence responses of dye was measured from time-lapse images, taken every 3 s. Five regions of interest were selected per image and the average background value was subtracted from the signal value from each pixel in the field. Axiovision-4 software was used to collect time-lapse measurements. Quantitative measurements of fluorescence intensity of individual puncta were obtained by averaging 4 × 4 pixels (0.4 × 0.4 µm 2 ). Experiments were done in pairs of control and Bcl-x L -overexpressing neurons at DIV 14.
Immunoprecipitation and western blot analysis. Lysates of hippocampal cultures (DIV 12) or adult whole brain were prepared with cell lysis buffer (10 mM HEPES, 1 mM EDTA (pH 7.4), 150 mM NaCl and 1% Triton X-100, supplemented with protease inhibitors (Roche Applied Science)) for immunoprecipitation and western blotting. Input represents 5% of total lysate. For translocation of endogenous Bcl-x L , all cultures overexpress GFP-Bcl-x L but the bands shown are those of endogenous Bcl-x L . All lanes contain 10 µg protein. For immunoprecipitation, cell lysate was mixed with primary antibody (1:1,000 dilution) in immunoprecipitation buffer (10 mM HEPES, 1 mM EDTA (pH 7.4), 150 mM NaCl and 1% Triton X-100, supplemented with protease inhibitors) and incubated overnight at 4 • C with gentle rocking. Protein A and G-Sepharose beads were added and allowed to incubate for 1 h. The unbound protein was removed by washing the beads three times in immunoprecipitation buffer. The bound protein was then eluted from the beads with SDS-PAGE sample buffer. Immunoprecipitated samples were analysed by western blotting, using previously published protocols 9 .
Western blot quantification. The quantification of protein levels was done using (http://rsb.info.nih.gov/ij/). Each band was normalized against its own internal control (lower bands). The values from independent experiments were then normalized against the mean of the group.
Sample fixation for immuno-electron microscopy. Samples were fixed in 4% paraformaldehyde in 0.25 M HEPES for 1 h. Samples were rinsed in PBS and re-suspended in 10% gelatin, chilled and trimmed to smaller blocks and placed in cryoprotectant of 2.3 M sucrose overnight on a rotor at 4 • C. They were transferred to aluminium pins and frozen rapidly in liquid nitrogen. The frozen block was trimmed on a Leica Cryo-EMUC6 UltraCut and 65-75-nm-thick sections were collected using the Tokoyasu method 63 . The frozen sections were collected on a drop of sucrose, thawed and placed on a nickel Formvar/carbon-coated grid and floated in a dish of PBS ready for immunolabelling.
Immunolabelling of sections. Grids were placed section side down on drops of 0.1 M ammonium chloride to quench untreated aldehyde groups, then blocked for nonspecific binding on 1% fish skin gelatin in PBS. Single-labelled grids were incubated on either a primary antibody rabbit anti-Bcl-X (Biocarta) 1:50, mouse anti-clathrin (Chemicon) 1:75 dilutions for 30 min, or DRP1 (H-300): sc-32898 (1:50) from Santa Cruz Biotechnology. A rabbit anti-mouse bridging antibody (Jackson) was used for the mouse primaries before rinsing and using 10 nm protein A gold (UtrectUMC) for 30 min. Double-labelled grids used the primary rabbit anti-Bcl-X and 10 nm protein A gold followed by rabbit anti-mouse bridge and the 5 nm protein A gold. All grids were rinsed in PBS, fixed using 1% glutaraldehyde for 5 min, rinsed and transferred to a UA/methylcellulose drop, then dried for viewing. Samples were viewed on an FEI Tecnai Biotwin TEM at 80 kV. Images were taken using a Morada CCD (charge-coupled device) and iTEM (Olympus) software.
Sample fixation for regular Epon embedding (for studies with Drp1 shRNA).
Cells on coverslips were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer at pH 7.4 with for 1 h. The samples were rinsed in sodium cacodylate postfixed in 1% osmium tetroxide for 1 h, en bloc stained in 2% uranyl acetate in maleate buffer at pH 5.2 for a further hour and then rinsed, dehydrated in an ethanol series and infiltrated with resin (Embed812 EMS). Resin-filled gelatin capsules were inverted over the coverslip and baked overnight at 60 • C. Sixty-nanometre sections were cut using a Leica UltraCut UCT, collected on nickel Formvar/carbon-coated grids, and stained using 2% uranyl acetate and lead citrate.
Protocol for HRP-staining neurons and labelling endocytic vesicles with HRP. Neurons were rinsed with Tyrode's buffer and incubated with 10 mg ml −1 HRP at 37 • C for 20 min. Cells were then stimulated with 90 mM KCl for 90 s following by 2× rinsing with ice-cold Tyrode's buffer. Neurons were fixed for 1 h with 1.2% glutaraldehyde and 0.1 M Na cacodylate and incubated for 10 min in 0.1 M ammonium phosphate at pH 7.4. Neurons were incubated for another 10 min in ammonium phosphate at pH 7.4. plus 0.5 mg ml −1 diaminobenzidine (DAB) followed by incubation in 0.1 M ammonium phosphate at pH 7.4, 0.5 mg ml −1 DAB and 0.005% H 2 O 2 for 5-15 min (until brown colour developed). Cells were rinsed 3× with cold water and fixed for 1 h in 1% OsO 4 , 1% K 4 Fe(CN) 6 and 0.1 M Na cacodylate, followed by 3 × 5 min washes with 0.1 M Na cacodylate and 3 × 5 min washes with water. Cells were stained overnight with 0.5% uranyl magnesium acetate (2 µm filtered) and washed 3 × 5 min with water, 2 × 5 min with 70% ethanol, 2 × 15 min with 95% ethanol, 2 × 30 minwith 100% ethanol, 1 h with 1:1 Epon/ethanol and 2 × 1 h with Epon. Cells were then embedded and baked for 48 h at 65 • C.
Subcellular fractionation. Mitochondrial, synaptosomal and cytosolic fractions
were prepared according to the manufacturer's protocol (Millipore catalogue number MIT1000). Briefly, cultured neurons were homogenized in isotonic mitochondrial buffer and centrifuged at 600g for 10 min at 4 • C. The pellet, containing the nuclear and unbroken cells, was discarded and the supernatant, containing the mitochondrial, synaptosomal and cytosolic fractions, was centrifuged at 10,000g for 30 min at 4 • C. The supernatant, containing the cytosolic fraction, was separated from the pellet. The pellet containing the mitochondrial and synaptosomal fractions was resuspended in 100 µl isolation buffer and layered onto a 7.5-10% Ficoll gradient. After 30 min ultracentrifugation at 90,000g, 4 • C, the mitochondrial pellet and the middle layer, containing synaptosomes, were removed and resuspended in isolation buffer and centrifuged for 10 min at 20,000g, resulting in a crude synaptosomal pellet. Synaptosomal pellet was lysed by hypo-osmotic shock in water. The samples were agitated for 30 min in 4 mM HEPES at 4 • C, and the synaptosomal pellet was centrifuged for 20 min at 25,000g, resulting in a synaptosomal membrane fraction (pellet) and a synaptic vesicle fraction. The latter was used for immunoblots.
Electrophysiology. Whole-cell patch-clamp recordings were performed on autaptic hippocampal neurons in culture. Data were acquired using a EPC8 amplifier and Clampex 9.0 software. Recordings were filtered at 1 kHz and sampled at 2 ms. The bath solution contained the following (in mM): 124 NaCl, 3 KCl, 10 HEPES, 5 d-glucose, 2 CaCl 2 and 1 MgCl 2 , at pH 7.3, 275 mOsm. The pipette internal solution contained the following (in mM): 120 K-gluconate, 8 NaCl, 0.5 EGTA, 10 HEPES, 1 Mg-ATP, and 10 QX-314, at pH 7.3, 265 mOsm. Stimulation was applied by depolarizing the cell through the recording electrode with the following membrane potential steps: −60 mV, 20 mV and −60 mV, at 10 Hz. Synaptic current responses to depolarization were recorded at −60 mV. Such currents were eliminated in the presence of CNQX/APV (data not shown). Series resistance ranged between 6 and 20 M .
Luciferase assay for in vitro ATP measurements. Cellular ATP levels were measured on acute cell membrane lysis of hippocampal neurons in a plate reader (Perkin-Elmer) in the presence of luciferin/luciferase (ApoSENSOR, Biovision).
